Lifespan-extending effects of royal jelly and its related substances on the nematode caenorhabditis elegans

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Honda, Yoko ^a   Fujita, Yasunori ^b   Maruyama, Hiroe ^c   Araki, Yoko ^c   Ichihara, Kenji ^c   Sato, Akira ^d   Kojima, Toshio ^d,e   Tanaka, Masashi ^a   Nozawa, Yoshinori ^b,f   Ito, Masafumi ^b   Honda, Shuji ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

^c API Company Limited   (Japan)

^d RIKEN   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKAI GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

10 HYDROXY 2 DECENOIC ACID; INSULIN; ROYAL JELLY; SILICON DIOXIDE; SOMATOMEDIN C; TRANSCRIPTION FACTOR DAF 16; TRANSCRIPTION FACTOR FOXO; 10-HYDROXY-2-DECENOIC ACID; CAENORHABDITIS ELEGANS PROTEIN; DAF 16 PROTEIN, C ELEGANS; DAF-16 PROTEIN, C ELEGANS; FATTY ACID; GREEN FLUORESCENT PROTEIN; MONOUNSATURATED FATTY ACID; PEPTIDE HYDROLASE; TRANSCRIPTION FACTOR;

ARTICLE; CAENORHABDITIS ELEGANS; COLUMN CHROMATOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DAO 4 GENE; DOD 19 GENE; DOD 3 GENE; DOWN REGULATION; FKB 4 GENE; FRACTIONATION; GENE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; INS 9 GENE; LIFE EXTENSION; LONGEVITY; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; ACTIVE TRANSPORT; AGING; ANIMAL; BEE; CELL NUCLEUS; CHEMISTRY; CHROMATOGRAPHY; DNA MICROARRAY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; METHODOLOGY; MUTATION; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; CAENORHABDITIS ELEGANS;

ACTIVE TRANSPORT, CELL NUCLEUS; AGING; ANIMALS; BEES; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CELL NUCLEUS; CHROMATOGRAPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; LONGEVITY; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE HYDROLASES; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 79961233299     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023527     Document Type: Article

References (96)

1. Kenyon C, (2005) The plasticity of aging: insights from long-lived mutants. Cell 120: 449-460.
2. Kenyon C, (2010) The genetics of ageing. Nature 464: 504-512.
3. Klass MR, (1977) Aging in the nematode Caenorhabditis elegans: major biological and environmental factors influencing life span. Mech Ageing Dev 6: 413-429.
4. Lithgow GJ, White TM, Melov S, Johnson TE, (1995) Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc Natl Acad Sci USA 92: 7540-7544.
5. Philpott DE, Bensch KG, Miquel J, (1974) Life span and fine structural changes in oxygen-poisoned Drosophila melanogaster. Aerosp Med 45: 283-289.
6. Honda S, Ishii N, Suzuki K, Matsuo M, (1993) Oxygen-dependent perturbation of life span and aging rate in the nematode. J Gerontol 48: B57-B61.
7. Honda Y, Tanaka M, Honda S, (2010) Redox regulation, gene expression and longevity. Geriat Gerontol Int 10: S59-S69.
8. Bordone L, Guarente L, (2005) Calorie restriction, sirt1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6: 298-305.
9. Gardner TS, (1948) The use of Drosophila melanogaster as a screening agent for longevity factors; pantothenic acid as a longevity factor in royal jelly. J Gerontol 3: 1-8.
10. Harrington LA, Harley CB, (1988) Effect of vitamin E on lifespan and reproduction in Caenorhabditis elegans. Mech Ageing Dev 43: 71-78.
11. Driver C, Georgeou A, (2003) Variable effects of vitamin E on Drosophila longevity. Biogerontology 4: 91-95.
12. Zou S, Sinclair J, Wilson MA, Carey JR, Liedo P, et al. (2007) Comparative approaches to facilitate the discovery of prolongevity interventions: Effects of tocopherols on lifespan of three invertebrate species. Mech Ageing Dev 128: 222-226.
13. Soukas AA, Kane EA, Carr CE, Melo JA, Ruvkun G, (2009) Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev 23: 496-511.
14. Hashimoto T, Horikawa M, Nomura T, Sakamoto K, (2010) Nicotinamide adenine dinucleotide extends the lifespan of Caenorhabditis elegans mediated by sir-2.1 and daf-16. Biogerontology 11: 31-43.
15. Honda Y, Tanaka M, Honda S, (2010) Trehalose extends longevity in the nematode Caenorhabditis elegans. Aging Cell 9: 558-569.
16. D'Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, et al. (2010) Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab 12: 362-372.
17. Winston ML, (1991) The biology of the honey bee. Cambridge, MA Harvard Univ Press.
18. Remolina SC, Hughes KA, (2008) Evolution and mechanisms of long life and high fertility in queen honey bees. Age (Dordr) 30: 177-185.
19. Page RE Jr, Peng CY, (2001) Aging and development in social insects with emphasis on the honey bee, Apis mellifera L. Exp Gerontol 36: 695-711.
20. Takenaka T, (1982) Chemical composition of royal jelly. Honeybee Sci 3: 69-74.
21. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S, (2010) AMP N1-oxide, a unique compound of royal jelly, induces neurite outgrowth from PC12 cells via signaling by protein kinase A independent of that by mitogen-activated protein kinase. Evid Based Complement Alternat Med 7: 63-68.
22. Fontana R, Mendes MA, de Souza BM, Konno K, Cesar LM, et al. (2004) Jelleines: a family of antimicrobial peptides from the Royal Jelly of honeybees (Apis mellifera). Peptides 25: 919-928.
23. Bíliková K, Hanes J, Nordhoff E, Saenger W, Klaudiny J, et al. (2002) Apisimin, a new serine-valine-rich peptide from honeybee (Apis mellifera L.) royal jelly: purification and molecular characterization. FEBS Lett 528: 125-129.
24. Gasic S, Vucevic D, Vasilijic S, Antunovic M, Chinou I, et al. (2007) Evaluation of the immunomodulatory activities of royal jelly components in vitro. Immunopharmacol Immunotoxicol 29: 521-536.
25. Henschler D, (1956) Identification of choline esters in biological material, especially acetylcholine in royal jelly of the bee. Hoppe-Seylers Z. physiol. Chem 305: 34-41.
26. Colhoun EH, Smith MV, (1960) Neurohormonal properties of royal jelly. Nature 188: 854-855.
27. Wei W, Wei M, Kang X, Deng H, Lu Z, (2009) A novel method developed for acetylcholine detection in royal jelly by using capillary electrophoresis coupled with electrogenerated chemiluminescence based on a simple reaction. Electrophoresis 30: 1949-1952.
28. Butenandt A, Rembold H, (1957) Royal jelly of the honeybee. I. Isolation, constitution analysis, and incidence of 10-hydroxy-delta 2-decenoic acid. Hoppe-Seylers Z physiol Chem 203: 284-289.
29. Inoue S, Koya-Miyata S, Ushio S, Iwaki K, Ikeda M, et al. (2003) Royal Jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage. Exp Gerontol 38: 965-969.
30. Fujiwara S, Imai J, Fujiwara M, Yaeshima T, Kawashima T, et al. (1990) A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J Biol Chem 265: 11333-11337.
31. Bincoletto C, Eberlin S, Figueiredo CA, Luengo MB, Queiroz ML, (2005) Effects produced by royal jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge. Int Immunopharmacol 5: 679-688.
32. Kataoka M, Arai-N, Taniguchi-Y, Kohno K, Iwaki K, et al. (2001) Analysis of anti-allergic function of royal jelly. J Nat Med 55: 174-180.
33. Kamakura M, Mitani N, Fukuda T, Fukushima M, (2001) Antifatigue effect of fresh royal jelly in mice. J Nutr Sci Vitaminol 47 Tokyo: 394-401.
34. Fujii A, Kobayashi S, Kuboyama N, Furukawa Y, Kaneko Y, et al. (1990) Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats. Jpn J Pharmacol 53: 331-337.
35. Kohno K, Okamoto I, Sano O, Arai N, Iwaki K, et al. (2004) Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages. Biosci Biotechnol Biochem 68: 138-145.
36. Okamoto I, Taniguchi Y, Kunikita T, Kohno K, Iwaki K, et al. (2003) Major royal jelly protein 3 modulates immune responses in vitro and in vivo. Life Sci 1: 2029-2045.
37. Erem C, Deger O, Ovali E, Barlak Y, (2006) The effects of royal jelly on autoimmunity in Graves' disease. Endocrine 30: 175-183.
38. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S, (2007) Royal jelly-induced neurite outgrowth from rat pheochromocytoma PC12 cells requires integrin signal independent of activation of extracellular signal-regulated kinases. Biomed Res 28: 139-146.
39. Taniguchi Y, Kohno K, Inoue S, Koya-Miyata S, Okamoto I, et al. (2003) Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. Int Immunopharmacol 3: 1313-1324.
40. Vittek J, (1995) Effect of royal jelly on serum lipids in experimental animals and humans with atherosclerosis. Experientia 51: 927-935.
41. Hidaka S, Okamoto Y, Uchiyama S, Nakatsuma A, Hashimoto K, et al. (2006) Royal jelly prevents osteoporosis in rats: beneficial effects in ovariectomy model and in bone tissue culture model. Evid Based Complement Alternat Med 3: 339-348.
42. Narita Y, Nomura J, Ohta S, Inoh Y, Suzuki KM, et al. (2006) Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines. Biosci Biotechnol Biochem 70: 2508-2514.
43. Nagai T, Inoue R, Suzuki N, Nagashima T, (2006) Antioxidant properties of enzymatic hydrolysates from royal jelly. J Med Food 9: 363-367.
44. Guo H, Ekusa A, Iwai K, Yonekura M, Takahata Y, et al. (2008) Royal jelly peptides inhibit lipid peroxidation in vitro and in vivo. J Nutr Sci Vitaminol 54 Tokyo: 191-195.
45. Matsui T, Yukiyoshi A, Doi S, Sugimoto H, Yamada H, et al. (2002) Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J Nutr Biochem 13: 80-86.
46. Tokunaga KH, Yoshida C, Suzuki KM, Maruyama H, Futamura Y, et al. (2004) Antihypertensive effect of peptides from royal jelly in spontaneously hypertensive rats. Biol Pharm Bull 27: 189-192.
47. Sultana A, Nabi AH, Nasir UM, Maruyama H, Suzuki KM, et al. (2008) A dipeptide YY derived from royal jelly proteins inhibits renin activity. Int J Mol Med 21: 677-681.
48. Wilson MA, Shukitt-Hale B, Kalt W, Ingram DK, Joseph JA, et al. (2006) Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell 5: 59-68.
49. Wu Z, Smith JV, Paramasivam V, Butko P, Khan I, et al. (2002) Ginkgo biloba extract EGb 761 increases stress resistance and extends life span of Caenorhabditis elegans. Cell Mol Biol (Noisy-le-grand) 48: 725-731.
50. Brown MK, Evans JL, Luo Y, (2006) Beneficial effects of natural antioxidants EGCG and alpha-lipoic acid on life span and age-dependent behavioral declines in Caenorhabditis elegans. Pharmacol Biochem Behav 85: 620-628.
51. Abbas S, Wink M, (2009) Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans. Planta Med 75: 216-221.
52. Yu H, Larsen PL, (2001) DAF-16-dependent and independent expression targets of DAF-2 insulin receptor-like pathway in Caenorhabditis elegans include FKBPs. J Mol Biol 314: 1017-1028.
53. Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, et al. (2003) Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424, 277-283.
54. Furuyama T, Nakazawa T, Nakano I, Mori N, (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349: 629-634.
55. Henderson ST, Johnson TE, (2001) daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol 11: 1975-1980.
56. Lin K, Hsin H, Libina N, Kenyon C, (2001) Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nature Genet 28: 139-145.
57. Blum MS, Novak AF, Taber S III, (1959) 10-Hydroxy-delta 2-decenoic acid, an antibiotic found in royal jelly. Science 130: 452-453.
58. Townsend GF, Morgan JF, Tolnai S, Hazlett B, Morton HJ, et al. (1960) Studies on the in vitro antitumor activity of fatty acids. I. 10-Hydroxy-2-decenoic acid from royal jelly. Cancer Res 20: 503-510.
59. Yang XY, Yang DS, Wei-Zhang, Wang JM, Li CY, et al. (2010) 10-Hydroxy-2-decenoic acid from Royal jelly: a potential medicine for RA. J Ethnopharmacol 128: 314-321.
60. Izuta H, Chikaraishi Y, Shimazawa M, Mishima S, Hara H, (2009) 10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells. Evid Based Complement Alternat Med 6: 489-494.
61. Hattori N, Nomoto H, Fukumitsu H, Mishima S, Furukawa S, (2007) Royal jelly and its unique fatty acid, 10-hydroxy-trans-2-decenoic acid, promote neurogenesis by neural stem/progenitor cells in vitro. Biomed Res 28: 261-266.
62. Koya-Miyata S, Okamoto I, Ushio S, Iwaki K, Ikeda M, et al. (2004) Identification of a collagen production-promoting factor from an extract of royal jelly and its possible mechanism. Biosci Biotechnol Biochem 68: 767-773.
63. Kinoshita G, Shuel RW, (1975) Mode of action of royal jelly in honeybee development. X Some aspects of lipid nutrition. Can J Zoology 53: 311-319.
64. Tatar M, Bartke A, Antebi A, (2003) The endocrine regulation of aging by insulin-like signals. Science 299: 1346-1351.
65. Corona M, Velarde RA, Remolina S, Moran-Lauter A, Wang Y, et al. (2007) Vitellogenin, juvenile hormone, insulin signaling, and queen honey bee longevity. Proc Natl Acad Sci U S A 104: 7128-7133.
66. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R, (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366: 461-464.
67. Lin K, Dorman JB, Rodan A, Kenyon C, (1997) daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278: 1319-1322.
68. Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, et al. (1997) The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389: 994-999.
69. Pierce SB, Costa M, Wisotzkey R, Devadhar S, Homburger SA, et al. (2001) Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family. Genes Dev 15: 672-686.
70. Kawano T, Nagatomo R, Kimura Y, Gengyo-Ando K, Mitani S, (2006) Disruption of ins-11, a Caenorhabditis elegans insulin-like gene, and phenotypic analyses of the gene-disrupted animal. Biosci Biotechnol Biochem 70: 3084-3087.
71. Kawano T, Ito Y, Ishiguro M, Takuwa K, Nakajima T, et al. (2000) Molecular cloning and characterization of a new insulin/IGF-like peptide of the nematode Caenorhabditis elegans. Biochem Biophys Res Comm 273: 431-436.
72. Malone EA, Inoue T, Thomas JH, (1996) Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics 143: 1193-1205.
73. Li W, Kennedy SG, Ruvkun G, (2003) daf-28 encodes a C. elegans insulin superfamily member that is regulated by environmental cues and acts in the DAF-2 signaling pathway. Genes Dev 17: 844-858.
74. Alcedo J, Kenyon C, (2004) Regulation of C. elegans longevity by specific gustatory and olfactory neurons. Neuron 41: 45-55.
75. Bishop NA, Guarente L, (2007) Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 447: 545-549.
76. Murphy CT, Lee SJ, Kenyon C, (2007) Tissue entrainment by feedback regulation of insulin gene expression in the endoderm of Caenorhabditis elegans. Proc Natl Acad Sci USA104: 19046-19050.
77. Brown EJ, Albers MW, Shin TB, Ichikawa K, Keith CT, et al. (1994) A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369: 756-758.
78. Sabatini DM, Erdjument-Bromage H, Lui M, Tempst P, Snyder SH, (1994) RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78: 35-43.
79. Chiu MI, Katz H, Berlin V, (1994) RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex. Proc Natl Acad Sci U S A 91: 12574-12578.
80. Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, et al. (1995) Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem 270: 815-822.
81. Bai X, Ma D, Liu A, Shen X, Wang QJ, et al. (2007) Rheb activates mTOR by antagonizing Its endogenous inhibitor, FKBP38. Science 318: 977-980.
82. Dunlop EA, Dodd KM, Seymour LA, Tee AR, (2009) Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognition. Cell Signal 21: 1073-1084.
83. Kang CB, Hong Y, Dhe-Paganon S, Yoon HS, (2008) FKBP family proteins: immunophilins with versatile biological functions. Neurosignals 16: 318-325.
84. Sabatini DM, Lai MM, Snyder SH, (1997) Neural roles of immunophilins and their ligands. Mol Neurobiol 15: 223-239.
85. Sanokawa-Akakura R, Cao W, Allan K, Patel K, Ganesh A, et al. (2010) Control of Alzheimer's amyloid beta toxicity by the high molecular weight immunophilin FKBP52 and copper homeostasis in Drosophila. PLoS One 5: e8626.
86. Kaeberlein M, Powers RW 3rd, Steffen KK, Westman EA, Hu D, et al. (2005) Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310: 1193-1196.
87. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, et al. (2003) Influence of TOR kinase on lifespan in C. elegans. Nature 426: 620.
88. Jia K, Chen D, Riddle DL, (2004) The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131: 3897-3906.
89. Sheaffer KL, Updike DL, Mango SE, (2008) The target of rapamycin pathway antagonizes pha-4/FoxA to control development and aging. Curr Biol 18: 1355-1364.
90. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, et al. (2004) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 14: 885-890.
91. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395.
92. Winter AD, Eschenlauer SC, McCormack G, Page AP, (2007) Loss of secretory pathway FK506-binding proteins results in cold-sensitive lethality and associate extracellular matrix defects in the nematode Caenorhabditis elegans. J Biol Chem 282: 12813-12821.
93. Patel A, Fondrk MK, Kaftanoglu O, Emore C, Hunt G, et al. (2007) The making of a queen: TOR pathway is a key player in diphenic caste development. PLoS One 2: e509.
94. Brenner S, (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71-94.
95. Suzuki K, Yoshida C, Tokunaga K, Maruyama H, Futamura Y, et al. (2003) Inhibition of angiotensin I-converting enzyme by protease digests from Royal jelly. J Jpn Soc Food Sci Technol 50: 286-288.
96. Honda Y, Tanaka M, Honda S, (2008) Modulation of longevity and diapause by redox regulation mechanisms under the insulin-like signaling control in Caenorhabditis elegans. Exp. Gerontol 43: 520-529.